Agnirva Space Premier League - Expedition #30099: Amyloid Aggregation in Space: What Microgravity Reveals About Protein Disorders

Amyloid aggregation plays a central role in diseases like Parkinson’s and Alzheimer’s. The experiment “Amyloid Aggregation,” conducted during Expedition 59/60 by the European Space Agency (ESA), investigates how amyloid proteins form in the absence of gravity. Principal Investigator Cristina Casalone, D.V.M., and her team from Italy aim to uncover how microgravity influences the kinetics and structure of amyloid fibrils.

On Earth, gravity affects how proteins move and interact. In microgravity, protein molecules diffuse more slowly, allowing scientists to observe their natural tendencies without sedimentation effects. This space-based experiment allows researchers to observe whether amyloid fibrils grow differently in space—perhaps more orderly or with different toxicities.

Initial findings suggest that microgravity promotes a slower but more organized aggregation of amyloids, potentially mimicking early disease stages. These results are essential for understanding the progression of neurodegenerative diseases and may inform new therapeutic approaches.

For biology and medicine students, this study highlights how space serves as a laboratory for understanding disease at a fundamental level. It also underscores how international cooperation and innovative thinking can lead to breakthroughs in health sciences.

Get certified with over 100 hours of immersive, self-paced learning in astronomy, cosmology, space technology, and climate science through the Agnirva Space Internship Program. Join, complete virtual projects, and earn a digital certificate to showcase your space fluency in interviews, resumes, and beyond.